Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...

Italy: A recent analysis of the FDA Adverse Event Reporting System (FAERS) database has provided new insights into the safety ...

GLP-1RA vs insulin use was associated with improved cardiovascular and kidney outcomes among patients with type 2 diabetes on dialysis.

New research shows that metabolic bariatric surgery offers substantial protective benefits for patients with chronic kidney ...

As Novo Nordisk A/S and Eli Lilly and Co. go head-to-head in the U.S. and Chinese glucagon-like peptide-1 receptor agonists ...

ZT002 was safe and well tolerated in both biweekly and monthly dosing arms in patients with overweight or obesity with a tolerability profile aligned with the GLP-1RA class – The open-label ...

Ozempic and Wegovy are branded versions of semaglutide made by pharmaceutical company Novo Nordisk. Ozempic has been ...